MTATP6P14

Across TCGA pan-cancer cohorts, MTATP6P14 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MTATP6P14’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MTATP6P14 RNA is repressed in tumor relative to normal tissue. In most cancer types MTATP6P14 is over-expressed in tumor, although a few such as KIRC and LUSC show the opposite, repressed pattern.

KIRC and LUSC are the cancer types where MTATP6P14 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTATP6P14 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	−0.011	.011	2	view →
LUSC	Male	All	−0.015	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

MTATP6P14–KIRC

Open the KIRC breakdown →